154 related articles for article (PubMed ID: 9108183)
1. IL-1beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia.
Lieberman D; Livnat S; Schlaeffer F; Porath A; Horowitz S; Levy R
Infection; 1997; 25(2):90-4. PubMed ID: 9108183
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children.
Xu XF; Li XJ; Liu JL; Wu L; Chen ZM
Cytokine; 2016 Oct; 86():73-78. PubMed ID: 27475111
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.
Ortqvist A; Hedlund J; Wretlind B; Carlström A; Kalin M
Scand J Infect Dis; 1995; 27(5):457-62. PubMed ID: 8588135
[TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
[TBL] [Abstract][Full Text] [Related]
5. Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia.
Vasconcellos ÂG; Clarêncio J; Andrade D; Cardoso MA; Barral A; Nascimento-Carvalho CM
Cytokine; 2018 Jul; 107():1-8. PubMed ID: 29158121
[TBL] [Abstract][Full Text] [Related]
6. Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia.
Burgmeijer EH; Duijkers R; Lutter R; Bonten MJM; Schweitzer VA; Boersma WG
Clin Respir J; 2019 Oct; 13(10):605-613. PubMed ID: 31310442
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.
Porath A; Schlaeffer F; Pick N; Leinonen M; Lieberman D
Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):863-70. PubMed ID: 9495665
[TBL] [Abstract][Full Text] [Related]
8. Levels of interleukin-2, interferon-gamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production.
Koh YY; Park Y; Lee HJ; Kim CK
Pediatrics; 2001 Mar; 107(3):E39. PubMed ID: 11230620
[TBL] [Abstract][Full Text] [Related]
9. Serum Cytokines and FeNO in School-Aged Children with Mycoplasma pneumoniae Pneumonia.
Jin HL; Zhan L; Mei SF; Shao ZY
Med Sci Monit; 2020 Jun; 26():e923449. PubMed ID: 32564053
[TBL] [Abstract][Full Text] [Related]
10. Increased Serum Interleukin-10 but not Interleukin-4 Level in Children with Mycoplasma pneumoniae Pneumonia.
Medjo B; Atanaskovic-Markovic M; Nikolic D; Radic S; Lazarevic I; Cirkovic I; Djukic S
J Trop Pediatr; 2017 Aug; 63(4):294-300. PubMed ID: 28057814
[TBL] [Abstract][Full Text] [Related]
11. Decreased Interleukin-10 Responses in Children with Severe Mycoplasma pneumoniae Pneumonia.
Ding S; Wang X; Chen W; Fang Y; Liu B; Liu Y; Fei G; Wang L
PLoS One; 2016; 11(1):e0146397. PubMed ID: 26751073
[TBL] [Abstract][Full Text] [Related]
12. Soluble B7-H3 elevations in hospitalized children with Mycoplasma pneumoniae pneumonia.
Chen ZR; Zhang GB; Wang YQ; Yan YD; Zhou WF; Zhu CH; Wang J; Ji W
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):362-6. PubMed ID: 24139879
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens.
Wagenvoort GHJ; Vlaminckx BJM; van Kessel DA; Geever RCL; de Jong BAW; Grutters JC; Bos WJW; Meek B; Rijkers GT
Vaccine; 2017 Sep; 35(37):4886-4895. PubMed ID: 28802755
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae and Mycoplasma pneumoniae coinfection in community acquired pneumonia.
Toikka P; Juvén T; Virkki R; Leinonen M; Mertsola J; Ruuskanen O
Arch Dis Child; 2000 Nov; 83(5):413-4. PubMed ID: 11040150
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
Sings HL
Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
[TBL] [Abstract][Full Text] [Related]
17. Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China.
Shangguan Z; Sun Q; Zhang M; Ding J; Yi L; Gao Y; Zhan A; Zhao R; Ci X
J Infect Dev Ctries; 2014 Oct; 8(10):1259-66. PubMed ID: 25313601
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia.
Chaudhry R; Nazima N; Dhawan B; Kabra SK
Indian J Pediatr; 1998; 65(5):717-21. PubMed ID: 10773927
[TBL] [Abstract][Full Text] [Related]
19. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
Antunes G; Evans SA; Lordan JL; Frew AJ
Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
[TBL] [Abstract][Full Text] [Related]
20. The relationship between serum endothelin (ET)-1 and wheezing status in the children with Mycoplasma pneumoniae pneumonia.
Chung HL; Kim SG; Shin IH
Pediatr Allergy Immunol; 2006 Jun; 17(4):285-90. PubMed ID: 16771782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
